(1 - 17 from 21
)
Print - SCYNEXIS Names Marco Taglietti, M.D., Chief Executive Officer
www.globenewswire.com
Yves Ribeill, Ph.D., to Remain President, Serve on Board of Directors. Carole Sable, M.D., Submits Resignation as Chief Medical Officer. RESEARCH TRIANGLE PARK, …
FDA turns down Forest/Gedeon Richter's antipsychotic - PMLiVEwww.pmlive.com › pharma_news › fda_turns_dow...
www.pmlive.com
Dr Marco Taglietti, president of the Forest Research Institute, was pragmatic in his response to the agency's request. He said: “Given the ...
sorted by relevance / date